drugset / Trial / NCT00857948
Dose Ranging Study of Ivermectin Treatment Conditioner in Subjects With Head Lice Infestation
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a Phase 2 single center study designed to compare the safety, local tolerability, and efficacy of 3 strengths of ivermectin treatment conditioner to placebo.
Timeline
- Start
- 2009-03
- Primary completion
- 2009-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivermectin | Small molecule | 0.15 % | Topical |
| Subject | Ivermectin | Small molecule | 0.25 % | Topical |
| Subject | Ivermectin | Small molecule | 0.5 % | Topical |